Spots Global Cancer Trial Database for chemoradiotherapy
Every month we try and update this database with for chemoradiotherapy cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Chemoradiotherapy With or Without Enteral Nutrition for Locally Advanced Thoracic Esophageal Carcinoma | NCT02399306 | Esophageal Squa... Enteral Nutriti... Chemoradiothera... | Enteral nutriti... radiotherapy | 18 Years - 75 Years | Sichuan Cancer Hospital and Research Institute | |
| To Compare the Effect of Different Nutritional Pathways on Improving Nutritional Status of Esophageal Cancer Patients Undergoing Chemoradiotherapy | NCT04199832 | Esophageal Squa... Chemoradiothera... Enteral Nutriti... | Dietary guidanc... | 18 Years - 75 Years | Tianjin Medical University Cancer Institute and Hospital | |
| By Comparing TPF Induction Chemotherapy Combined With Nimotuzumab Concurrent Radiotherapy and Cisplatin Concurrent Radio-chemotherapy for Locally Advanced NPC | NCT03557112 | Nasopharyngeal ... | Nimotuzumab Cisplatin | 18 Years - 70 Years | Guiyang Medical University | |
| Induction Chemotherapy for Locally Advanced Rectal Cancer | NCT04838496 | Rectal Cancer | FOLFOXIRI Proto... | 18 Years - | Catharina Ziekenhuis Eindhoven | |
| Preoperative Radiochemotherapy With Hyperthermia for Locally Advanced Rectal Cancer | NCT02353858 | Rectal Cancer Locally Advance... Hyperthermia Hyperthermic Ra... Hyperthermic Ch... Deep Regional H... | Deep regional h... Radiotherapy Chemotherapy (5... | 18 Years - 80 Years | University Hospital Tuebingen | |
| Characterizing Chemo-Radiotherapy Treatment-Related Cardiac Changes | NCT04183218 | Clinical Stage ... Clinical Stage ... Clinical Stage ... Clinical Stage ... Clinical Stage ... Clinical Stage ... Clinical Stage ... Clinical Stage ... Clinical Stage ... Clinical Stage ... Localized Esoph... Localized Lung ... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Postneoadjuvant... Postneoadjuvant... Postneoadjuvant... Postneoadjuvant... Postneoadjuvant... Postneoadjuvant... Postneoadjuvant... Postneoadjuvant... Postneoadjuvant... Postneoadjuvant... Stage 0 Lung Ca... Stage I Lung Ca... Stage IA1 Lung ... Stage IA2 Lung ... Stage IA3 Lung ... Stage IB Lung C... Stage II Lung C... Stage IIA Lung ... Stage IIB Lung ... Stage III Lung ... Stage IIIA Lung... Stage IIIB Lung... Stage IIIC Lung... | Biospecimen Col... Cardiac Event M... Chemoradiothera... Radiation Thera... | 18 Years - | Mayo Clinic | |
| Toripalimab With Preoperative Chemoradiotherapy for LA-EGJ | NCT04061928 | PD-1 Chemoradiothera... Gastroesophagea... | PD-1 | 18 Years - 75 Years | Peking University | |
| MRI Guided SIB Radiotherapy in Neoadjuvant Therapy for Advanced Rectal Cancer | NCT06246344 | Rectal Cancer | MRI Guided Simu... | 18 Years - 75 Years | Shandong Cancer Hospital and Institute | |
| Assessing the Efficacy and Safety of Selective Metabolically Adaptive Radiation Dose Escalation in Locally Advanced Non-Small Cell Lung Cancer Receiving Definitive Chemoradiotherapy | NCT02788461 | Non-Small Cell ... | Chemoradiothera... Chemoradiothera... | 18 Years - | Lawson Health Research Institute | |
| Evaluation the Effects of Herbal Gargle for Chemoradiotherapy-induced Oral Mucositis of Head & Neck Cancer, a Pilot Study. | NCT05341206 | Head and Neck N... Chemoradiothera... Stomatitis and ... | Herbal gargle Normal saline | 20 Years - | Chang Gung Memorial Hospital | |
| A Pilot Study of Additional Chinese Formula for Concurrent Chemoradiotherapy in Oral Cavity Cancer Patients | NCT05590650 | Head and Neck N... Chemoradiothera... | SZKJT(San-Zhong... | 20 Years - 65 Years | China Medical University Hospital | |
| A Study of Camrelizumab Plus Apatinib as Consolidation Therapy in Non-Small Cell Lung Cancer Patients Treated With Chemoradiotherapy | NCT04749394 | Locally Advance... | Camrelizumab, P... Apatinib, VEGFR... | 18 Years - | ChineseAMS | |
| Nutrition and Cancer Outcomes in Shaanxi Chemoradiotherapy | NCT06219083 | Cancer Chemoradiothera... Nutrition, Heal... Oncology Clinical Outcom... | 18 Years - | Health Science Center of Xi'an Jiaotong University | ||
| Paclitaxel Plus Radiation With Erlotinib to Treat Esophageal Squamous Carcinoma | NCT01752205 | Esophageal Squa... | Paclitaxel Erlotinib Radiation thera... | 18 Years - | The Affiliated Hospital of the Chinese Academy of Military Medical Sciences | |
| Capecitabine in the Perioperative Treatment of Rectal Cancer | NCT01500993 | Rectal Cancer | Capecitabine 5-FU | 18 Years - | Universitätsmedizin Mannheim | |
| Study of Durvalumab With Chemoradiotherapy for Women With Locally Advanced Cervical Cancer (CALLA) | NCT03830866 | Locally Advance... | Durvalumab Cisplatin Carboplatin external beam r... | 18 Years - 130 Years | AstraZeneca | |
| Chemotherapy, Radiation Therapy, and Cetuximab Followed by Surgery, Docetaxel, and Cetuximab in Treating Patients With Esophageal Cancer or Gastroesophageal Junction Cancer | NCT00551759 | Esophageal Canc... | 5-Fluorouracil Oxaliplatin Cetuximab Docetaxel Surgery Radiotherapy | 18 Years - | Eastern Cooperative Oncology Group | |
| Chemoradiotherapy for Limited Advanced Unresectable Thymic Epithelial Tumors | NCT02636556 | Thymoma and Thy... | concurrent chem... | 18 Years - 75 Years | Fudan University | |
| Icotinib With Concurrent Radiotherapy Versus Chemotherapy With Concurrent Radiotherapy in Non-small Cell Lung Cancer | NCT02215356 | Non-small Cell ... | Icotinib with c... Chemoradiothera... | 18 Years - 75 Years | Betta Pharmaceuticals Co., Ltd. | |
| Association Between Tinnitus and Hearing Loss in Locally Advanced Head and Neck Cancer Treated by Radiotherapy Alone or With Chemotherapy: a Prospective and Multicenter Study | NCT05946577 | Head Cancer Neck Cancer | 18 Years - | Assistance Publique - Hôpitaux de Paris | ||
| EUS-RFA for Unresectable Pancreatic Ductal Adenocarcinoma | NCT03772756 | Pancreatic Aden... | Endoscopic ultr... chemoradiothera... | 20 Years - 80 Years | First People's Hospital of Hangzhou | |
| PD-1 Antibody Plus Chemoradiotherapy for IB2-IIIB Cervical Cancer | NCT05311566 | Cervical Carcin... Chemoradiothera... Anti-programmed... Immunotherapy Immune Checkpoi... Survival Outcom... Adverse Events Early Stage Cer... Locally Advance... | Camrelizumab pl... | 18 Years - | Peking Union Medical College Hospital | |
| A Phase III Study of Comparing Paclitaxel Plus 5-Fluorouracil Versus Cisplatin Plus 5-Fluorouracil in Chemoradiotherapy for Locally Advanced Esophageal Carcinoma | NCT01591135 | Esophageal Squa... | Paclitaxel plus... Cisplatin plus ... Radiation thera... Radiation thera... | 18 Years - 75 Years | Fudan University | |
| Timing for Rectal Surgery After Chemoradiotherapy | NCT03607370 | Rectal Cancer | Surgery after 1... | 18 Years - 99 Years | National Cancer Institute, Lithuania | |
| Effect of Immunonutrients on Oral Mucositis in Nasopharyngeal Carcinoma Patients After Chemoradiotherapy | NCT05892354 | Locally Advance... | Enteral immunon... Standard entera... | 18 Years - 70 Years | First Affiliated Hospital of Guangxi Medical University | |
| RCT on the Combined Modality Treatment of Squamous Cell Carcinoma of the Esophagus | NCT00559351 | Esophageal Neop... Squamous Cell C... | transthoracic e... neoadjuvant che... neoadjuvant che... | 18 Years - 75 Years | Ministry of Scientific Research and Information Technology, Poland | |
| A Study of Camrelizumab Plus Apatinib as Consolidation Therapy in Non-Small Cell Lung Cancer Patients Treated With Chemoradiotherapy | NCT04749394 | Locally Advance... | Camrelizumab, P... Apatinib, VEGFR... | 18 Years - | ChineseAMS | |
| Chemoradiation With Enadenotucirev as a Radiosensitiser in Locally Advanced Rectal Cancer | NCT03916510 | Locally Advance... | Enadenotucirev Capecitabine Radiotherapy | 18 Years - | University of Oxford | |
| Study of Docetaxel/Gemcitabine Followed by Chemo-radiotherapy (Chemo-RT), With or Without Consolidation Chemotherapy, in IIIA/IIIB Non Small Cell Lung Cancer (NSCLC) | NCT00431613 | Non Small Cell ... | Docetaxel Gemcitabine Carboplatin Chemoradiothera... Docetaxel | 19 Years - 75 Years | Hellenic Oncology Research Group | |
| Effect of Preoperative Chemoradiotherapy on Exercise Capacity as Measured by Cardiopulmonary Exercise Testing | NCT00833508 | Colorectal Canc... | Cardiopulmonary... | 65 Years - | Imperial College London | |
| Study of Nivolumab for Non-Small Cell Lung Cancer (Stage III) Following Neoadjuvant Chemotherapy Plus Nivolumab and Definitive Concurrent Chemoradiation Therapy | NCT04085250 | Stage III Non-s... | Neoadjuvant the... Chemotherapy co... Radiotherapy Nivolumab Observation | 18 Years - 75 Years | Sun Yat-sen University | |
| Toripalimab in Combination With Chemotherapy as Induced Chemotherapy for Localized Hypopharyngeal Cancer | NCT04296747 | Hypopharyngeal ... | induction chemo... surgery chemoradiothera... | 18 Years - | Peking Union Medical College Hospital | |
| Analysis of Nutrition During Chemoradiotherapy in Patients With Gastrointestinal Cancer | NCT03286348 | Nutritional Sta... Gastrointestina... Chemoradiothera... | 18 Years - 70 Years | Fudan University | ||
| Different Cycles of Capecitabine Usage in Esophageal Cancer Concurrent Chemoradiotherapy | NCT02603159 | Stage III Esoph... Stage II Esopha... | Capecitabine(Ai... radiotherapy | 45 Years - 75 Years | The First Affiliated Hospital of Henan University of Science and Technology | |
| Prevention of Upper Gastrointestinal Hemorrhage Using Albis® in the Patients of Locally Advanced Pancreatic Cancer Who Underwent Concurrent Chemoradiotherapy | NCT02570529 | Pancreatic Duct... | Albis® Placebo | 20 Years - 80 Years | Yonsei University | |
| Induction Chemotherapy Followed by Chemoradiotherapy in Esophageal Cancer | NCT02403531 | Neoplasms | Docetaxel Cisplatin Radiotherapy | 18 Years - 70 Years | Sun Yat-sen University | |
| Hypofractionated Radiotherapy With Sequential Chemotherapy in Marginally Resectable Soft Tissue Sarcomas of Extremities or Trunk Wall | NCT03651375 | Sarcoma Fibrosarcoma Leiomyosarcoma Liposarcoma Myosarcoma Histiocytic Sar... Synovial Sarcom... Lymphangiosarco... Malignant Perip... Myxofibrosarcom... Myxoid Liposarc... Undifferentiate... Pleomorphic Lip... Undifferentiate... Dedifferentiate... Pleomorphic Rha... Malignant Trito... | Sequential chem... Hypofractionate... | 18 Years - 100 Years | Maria Sklodowska-Curie National Research Institute of Oncology | |
| Predictive Biomarkers for Pneumonitis After Chemoradiotherapy and Immunotherapy in Patients With Non-small Cell Lung Cancer | NCT04913311 | Lung Non-Small ... | Biospecimen Col... Bronchoscopy wi... Chemoradiothera... Computed Tomogr... Diagnostic Labo... Immune Checkpoi... Nasal Wash and ... Quality-of-Life... Questionnaire A... Spirometry | - | M.D. Anderson Cancer Center | |
| Tirelizumab in Combination With Chemoradiation in Patients With Unresectable Gastric Cancer or Gastroesophageal Junction Adenocarcinoma | NCT05528367 | Locally Advance... | Nab-PTX,S-1,Tir... Chemoradiation | 18 Years - 75 Years | Zhejiang Cancer Hospital | |
| Chemoradiotherapy in Unresectable Esophageal Cancer | NCT04278287 | Esophageal Canc... Chemoradiothera... Albumin-bound P... Unresectable Ma... | Radiotherapy Albumin-Bound P... Cisplatin | 18 Years - 75 Years | ChineseAMS | |
| Trimodality Management of T1b Esophageal Cancers | NCT01217060 | Esophageal Canc... | Docetaxel 5-FU Radiotherapy Esophagectomy Dexamethasone | 18 Years - | M.D. Anderson Cancer Center | |
| Surgery Plus Chemo Versus Chemoradiotherapy Followed by Surgery Plus Chemo for Locally Recurrent Rectal Cancer | NCT04288999 | Rectal Cancer R... | Chemotherapy Preoperative ra... Procedure | 20 Years - 80 Years | National Cancer Center Hospital East | |
| Durvalumab Combined With Chemoradiotherapy for Limited Stage Small Cell Lung Cancer (Camel-01) | NCT06371482 | SCLC, Limited S... | Durvalumab Chemotherapy dr... radiotherapy | 18 Years - 75 Years | Hebei Medical University Fourth Hospital | |
| Neoadjuvant Chemoradiotherapy vs. Chemotherapy With Radical Gastrectomy and Adjuvant Chemotherapy for Advanced Gastric Cancer | NCT01815853 | Gastric Cancer | Neoadjuvant Che... Neoadjuvant Che... R0 D2 Gastrecto... Adjuvant Chemot... | 18 Years - 75 Years | Sun Yat-sen University | |
| Preoperative Chemo and Chemoradiotherapy for Adenocarcinoma of the Stomach and Gastroesophageal Junction (GEJ) | NCT00525785 | Stomach Cancer Gastric Cancer | 5-Fluorouracil Folinic Acid Oxaliplatin Radiotherapy Surgery | 18 Years - 75 Years | M.D. Anderson Cancer Center | |
| Therapeutic Gain by Induction-concurrent Chemoradiotherapy and/or Accelerated Fractionation for Nasopharyngeal Carcinoma | NCT00379262 | Nasopharyngeal ... | Capecitabine Adjuvant chemot... Induction chemo... | 18 Years - 70 Years | Hong Kong Nasopharyngeal Cancer Study Group Limited | |
| Bevacizumab and Radiotherapy for Oligometastasis of Lung Adenocarcinoma With Negative Driver Gene | NCT03905317 | Lung Adenocarci... | Bevacizumab Inj... chest radiation concurrent chem... | 18 Years - 75 Years | Sun Yat-sen University | |
| Adjuvant Concurrent Chemoradiotherapy Versus Radiotherapy in Early-stage Cervical Cancer Patients | NCT05277688 | Cervical Cancer | adjuvant concur... radiotherapy | 18 Years - 80 Years | Ruijin Hospital | |
| Chemotherapy and Locoregional Therapy Trial (Surgery or Radiation) for Patients With Head and Neck Cancer | NCT03107182 | HPV-Related Squ... HNSCC | nab-paclitaxel Carboplatin Nivolumab Cisplatin Hydroxyurea 5-FU Dexamethasone Famotidine Diphenhydramine Paclitaxel Transoral robot... Adjuvant RT Chemoradiothera... | 18 Years - | University of Chicago | |
| Proximal Molecular Effects of Concurrent Chemoradiotherapy on Head and Neck Squamous Cell Carcinoma | NCT00620139 | Head and Neck S... | the arachidonic... | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Phase I Study of Olaparib Combined With Cisplatin-based Chemoradiotherapy to Treat Locally Advanced Head and Neck Cancer | NCT02308072 | Head and Neck C... | Olaparib Cisplatin IMRT | 18 Years - | University College, London | |
| Therapeutic Gain by Induction-concurrent Chemoradiotherapy and/or Accelerated Fractionation for Nasopharyngeal Carcinoma | NCT00379262 | Nasopharyngeal ... | Capecitabine Adjuvant chemot... Induction chemo... | 18 Years - 70 Years | Hong Kong Nasopharyngeal Cancer Study Group Limited | |
| Proximal Molecular Effects of Concurrent Chemoradiotherapy on Head and Neck Squamous Cell Carcinoma | NCT00620139 | Head and Neck S... | the arachidonic... | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Proximal Molecular Effects of Concurrent Chemoradiotherapy on Head and Neck Squamous Cell Carcinoma | NCT00620139 | Head and Neck S... | the arachidonic... | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| SOX-based CRT for Esophageal Cancer. | NCT03991104 | Esophageal Canc... | Oxaliplatin S-1 capsule Intensity modul... | 18 Years - 70 Years | Zhejiang Provincial People's Hospital | |
| Simultaneous Integrated Boost Preoperative Radiotherapy for Rectum Cancer | NCT01224392 | Rectal Cancer | Chemoradiothera... Radiotherapy wi... | 18 Years - 95 Years | Universitair Ziekenhuis Brussel | |
| CRT Versus Surgery for Retroperitoneal or Paraaortic Lymph Node Recurrence of CRC | NCT03725254 | Colorectal Canc... Retroperitoneal... Para-aortic Lym... | lymphadenectomy chemoradiothera... | 18 Years - 75 Years | Fudan University | |
| Sintilimab After Concurrent Chemoradiotherapy in Elderly Patients With Esophageal Squamous Cell Carcinoma | NCT06413342 | Esophageal Canc... Chemoradiothera... Sintilimab Immunotherapy Elderly Patient... | Sintilimab | 70 Years - 85 Years | Zhejiang Cancer Hospital | |
| The Role of Different Cycles of Chemotherapy（Capecitabine-oxaliplatin） in Esophageal Chemoradiotherapy | NCT02604615 | Stage III Esoph... Esophageal Neop... | Capecitabine(Ai... Oxaliplatin(Aih... Radiotherapy | 45 Years - 75 Years | The First Affiliated Hospital of Henan University of Science and Technology | |
| COr Loco-regional Advanced Lung Cancer Treated With Chemo-radiotherapy (COLA) | NCT05258448 | Cardiac Toxicit... Lung Cancer Sta... Lung Cancer Sta... Radiation Toxic... Cardiac Disease | Chemoradiothera... | 18 Years - | Odense University Hospital | |
| Different Cycles of Cisplatin-5-fluorouracil for the Chemoradiotherapy of Esophageal Squamous Cancer | NCT02607540 | Stage III Esoph... Stage II Esopha... | 2 cycles cispla... 4 cycles cispla... Radiotherapy | 45 Years - 75 Years | The First Affiliated Hospital of Henan University of Science and Technology | |
| Special Care Patterns for Elderly HNSCC Patients Undergoing Radiotherapy | NCT05337631 | HNSCC Oral Cavity Can... Oropharynx Canc... Hypopharynx Can... Larynx Cancer | 65 Years - | University Hospital Freiburg | ||
| Construction of CT Radiomics Model for Predicting the Efficacy of Immunotherapy in Patients With Stage III NSCLC | NCT04984148 | Stage III Non-s... | CT | 18 Years - | Guangdong Provincial People's Hospital | |
| Phase I Study of Olaparib With Cisplatin Based Chemoradiotherapy in Squamous Cell Carcinoma of the Head and Neck | NCT01491139 | Carcinoma, Squa... | olaparib cisplatin Intensity Modul... | 18 Years - | University College, London | |
| Feasibility Trial of Neoadjuvant Chemoradiotherapy for Locally Advanced Gastric Cancer | NCT01381913 | Gastric Cancer Chemoradiation | 20 Years - 80 Years | Kagawa University | ||
| Chemoradiotherapy Following Immunotherapy Plus Chemotherapy for Locally-advanced Esophageal Squamous Cell Cancer (RICE) | NCT05621707 | Esophageal Squa... Concurrent Chem... Immunotherapy Chemotherapy | chemotherapy co... | 18 Years - 75 Years | Shanghai Chest Hospital | |
| Prevention of Upper Gastrointestinal Hemorrhage Using Albis® in the Patients of Locally Advanced Pancreatic Cancer Who Underwent Concurrent Chemoradiotherapy | NCT02570529 | Pancreatic Duct... | Albis® Placebo | 20 Years - 80 Years | Yonsei University | |
| International Penile Advanced Cancer Trial (International Rare Cancers Initiative Study) | NCT02305654 | Squamous Cell C... | ILND - Inguinal... Paclitaxel Ifosfamide Cisplatin Intensity modul... Prophylactic PL... | 18 Years - | Institute of Cancer Research, United Kingdom | |
| Consolidation of Toripalimab After Chemoradiotherapy in Elderly Esophageal Cancer (EC-CRT-007) | NCT06187597 | Locally Advance... | S-1 Toripalimab Intensity-modul... | 70 Years - 85 Years | Sun Yat-sen University | |
| Endostar in Combination With Chemoradiotherapy in Patient With Advanced Non-small Cell Lung Cancer | NCT03588494 | Quality of Life | concurrent chem... Endostar for on... Endostar for tw... | 18 Years - 70 Years | Affiliated Hospital of North Sichuan Medical College | |
| Hearing Toxicity of Nasopharyngeal Carcinoma After Chemoradiotherapy | NCT05330169 | Nasopharyngeal ... | 18 Years - 60 Years | Guangxi Medical University | ||
| Neoadjuvant Comprehensive Treatment for Unresectable Esophageal Cancer | NCT06430658 | Esophagus Cance... | Tislelizumab (B... | 18 Years - 75 Years | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | |
| Bevacizumab and Carboplatin/Paclitaxel and Radiation in Non-Small Cell Lung Cancer | NCT00578149 | Non-Small Cell ... | Bevacizumab Carboplatin Paclitaxel | 18 Years - | Dana-Farber Cancer Institute | |
| Chemoradiotherapy in Patients With Localised Lung Cancer | NCT00193921 | Non Small Cell ... | Vinorelbine High dose Radio... Gemcitabine Cisplatin High Dose Radio... | 18 Years - | Trans Tasman Radiation Oncology Group | |
| Study to Assess Neoadjuvant Durvalumab (D) and Platinum-Based Chemotherapy (CT), Followed by Either Surgery and Adjuvant D or CRT and Consolidation D, in Resectable or Borderline Resectable Stage IIB-IIIB NSCLC (MDT-BRIDGE) | NCT05925530 | Non-small Cell ... | Durvalumab | 18 Years - 130 Years | AstraZeneca | |
| Study to Evaluate Palifermin in the Reduction of Dysphagia in Patients With Locally Advanced Non-Small Cell Lung Cancer (NSCLC) | NCT00094861 | Dysphagia Non-Small Cell ... Lung Cancer | Palifermin Placebo Radiotherapy Paclitaxel Carboplatin | 18 Years - | Swedish Orphan Biovitrum | |
| Phase II Study of Postoperative Concurrent Chemoradiotherapy for Esophageal Squamous Cell Carcinoma (ESO- Shanghai 17) | NCT04764227 | Esophagus Cance... Esophageal Squa... Chemoradiothera... Radiation Thera... Postoperative | Paclitaxel Carboplatin Radiotherapy | 18 Years - 75 Years | Fudan University | |
| Phase III Study of Concurrent Radiotherapy in Elderly Patients With Esophageal Squamous Cell Carcinoma (ESO-Shanghai 15) | NCT04519905 | Esophageal Squa... Chemoradiothera... Survival | Paclitaxel plus... radiotherapy | 76 Years - | Fudan University | |
| Endostatin in Combination With Oxaliplatin and Radiotherapy in Esophageal Cancer Patients. | NCT02745561 | Esophageal Canc... Endostatin | Endostatins Oxaliplatin Radiotherapy | 18 Years - 80 Years | Hangzhou Cancer Hospital | |
| Neoadjuvant Chemoradiotherapy vs. Chemotherapy With Radical Gastrectomy and Adjuvant Chemotherapy for Advanced Gastric Cancer | NCT01815853 | Gastric Cancer | Neoadjuvant Che... Neoadjuvant Che... R0 D2 Gastrecto... Adjuvant Chemot... | 18 Years - 75 Years | Sun Yat-sen University |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
